Address
Johnson & Johnson Development Corp Inc
410 George Street
New Brunswick, NJ 08933
United States
Phone
Website
VCID: 1964
Profile
Corporate information
Official name
Johnson & Johnson Innovation LLC
Also known as
JJDC Inc
Johnson & Johnson Development Corp Inc
Affiliate of
Investment activity status
Active investor
Company type
Accelerator of early-stage innovation worldwide that forms collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses.Team
Current employees
![[node:title] photo](/sites/default/files/styles/icon/public/default_images/icon-person.png?itok=8SSzz6Wf "[node:title] photo"){kind=icon}
|
Richard V McCloskey |
Investments
Investment preferences
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Medicxi Ventures I |
United Kingdom | 2 Feb 2016 | Fund Closing Active |
|
|
Inivata Ltd Clinical cancer genomics company focused on harnessing the potential of circulating tumor DNA (ctDNA) analysis to improve cancer testing and treatment |
United Kingdom | 23 Sep 2014 | N/A Active |
|
|
Aquinox Pharmaceuticals Inc Developer of small molecule therapeutics for the treatment of inflammatory disease |
Canada | 4 Apr 2013 | Series C Active |
|
|
|
Astute Medical Inc Dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers |
United States | 1 Jun 2012 1 Mar 2011 |
Series C |
|
|
|
Mitralign Inc Percutaneous mitral valve repair system. |
United States | 1 May 2012 | Series D |
|
|
|
PowerVision Inc |
United States | 1 Jan 2012 | Series C |
|
|
|
Spinal Modulation Inc Medical devices research and development company. |
United States | 9 Nov 2009 15 Jun 2011 |
Series D Active |
|
|
23andMe Inc DNA testing and genome sequencing firm. |
United States | 7 Jan 2011 9 Nov 2010 |
Series C Active |
|
|
|
Genocea Biosciences Inc |
United States | 1 Jan 2011 | Series B |
|
|
|
Breathe Technologies Inc Developer and manufacturer of innovative therapeutic respiratory systems. |
United States | 20 May 2010 | Series C Active |
|
|
Molecular Partners AG |
Switzerland | 1 Dec 2009 | Series B Active |
|
|
|
Direct Flow Medical Inc Medical device developer |
United States | 1 Oct 2009 | Series C Follow-on investment. Round participant. Active |
|
|
|
CoAxia Inc A medical device company that researches therapy and treatment solutions for cerebral ischemia |
United States | 1 Jun 2009 | Series D |
|
|
|
Cougar Biotechnology Inc |
United States | 21 May 2009 | Acquisition Active |
|
|
|
iScience Interventional Inc Leading the discovery and development of the product platforms used in Interventional Ophthalmology |
United States | 1 May 2009 | Series F |
|
|
|
Catalyst Biosciences Inc Developer of catalytic biopharmaceutical products based on engineered human proteases. |
United States | 1 Dec 2008 | Series C |
|
|
|
Biolex Therapeutics Inc |
United States | 1 Oct 2008 | Series D Active |